提醒:代购产品,无质量问题不接受退换货,下单前请仔细核对信息。下单后请及时联系客服 核对商品价格,订单生效后再付款。
Altogen/MIA PaCa-2 Transfection Kit (Pancreatic Carcinoma)/0.5 ml(Catalog #6850)
价格:

自营商城

解放采购

正品保障

及时交付

厂家直采

一站服务

品牌:
会员服务:
尊享会员价
贵宾专线
运费优惠
闪电退款
福利优惠
上门换新
友情提示
以上价格仅为参考,请联系客服询价。
免费咨询热线
4000-520-616
产品说明
DescriptionProduct Availability: In Stock (delivery within 2-3 business days, no extra charge for drop-shipping).Ordering: To place an order via credit card or PO use Add to Cart button (creating an account is not required).Transfection Reagent for MIA PaCa-2 Cells (Pancreatic Carcinoma Cells, CRL-1420)Proprietary cationic lipids formulationHigh transfection efficiency of small RNA (siRNA, shRNA, miRNA), mRNA, pDNAEffective and robust intracellular deliveryWork in the presence of serumOptimized transfection protocols are adapted for use with both standard & reverse transfection methodsDownload in vitro MiaPaCa2 transfection protocol: [PDF]Download MiaPaCa2 CRISPR/Cas9 transfection protocol: [PDF]Download PowerPoint presentation for Mia-PaCa-2 cells transfection kit: [PPT]Developed and manufactured by Altogen BiosystemsTransfection Efficiency:Reagent exhibits at least 88% transfection efficiency of siRNA delivery. Transfection efficiency was determined by qRT-PCR.Transfection Protocol and MSDS:Download Altogen Biosystems MiaPaCa-2 Transfection Protocol: [PDF]Download MSDS: [PDF]MIA PaCa-2 Cell Line:Pancreatic adenocarcinoma is an aggressive malignancy that is often advanced at the time of initial diagnosis due to the lack of early symptoms and reliable screening tests as well as rapid progression of the disease. Established cell lines have proven to be a useful tool for investigating the epidemiology of pancreatic cancer.  The MIA PaCa-2 cell line was initially isolated by A. Yunis et al. in 1975 using pancreatic tumor cells of a 65-year-old Caucasian male with pancreatic carcinoma. The tumor was negative for an alkaline phosphatase stain and did not express high amounts of carcinoembryonic antigen. This is a hypotriploid cell line with floating rounded cells that display epithelial morphology. MIA PaCa-2 cells produce plasminogen activator and human colony-stimulating factor (CSF-1). The modal chromosome number for this cell line is 61, and a few normal chromosomes are absent. MIA PaCa-2 has a doubling time of roughly 40 hours and is an excellent host for biomedical research related to pancreatic cancer. Altogen Biosystems provides lipid-based transfection reagent kits for the MIA PaCa-2 cell line.Data:Figure 1. Cyclophilin B silencing efficiency was determined by qRT-PCR in the MIA Paca-2 cells transfected by Cyclophilin B siRNA or non-silencing siRNA control following the recommended transfection protocol. Cyclophilin mRNA expression levels were measured 48 hours post-transfection. 18S rRNA levels were used to normalize the Cyclophilin B data. Values are normalized to untreated sample. Data are presented as means ± SD (n=6).Figure 2. Protein expression of Cyclophilin B in MIA PaCa-2 cells. DNA plasmid expressing Cyclophilin B or siRNA targeting Cyclophilin B were transfected into MIA PaCa-2 cells following Altogen Biosystems transfection protocol. At 72 hours post-transfection the cells were analyzed by Western Blot for protein expression levels (normalized by total protein, 10 µg of total protein loaded per each well). Untreated cells used as a negative control. Request a Quote forMIA PaCa-2 Transfection KitAltogen Biosystems: Altogen Biosystems manufacturers preoptimized transfection kits for cancer research. Reagents and transfection protocols are optimized for individual cancer cell lines. Altogen Biosystems developed two types of in vivo delivery kits for animal research: Tissue-targeted reagents (delivery into liver, pancreas, and kidney tissues), and in vivo biodistribution reagents (PEG-Liposome, Nanoparticle, Lipid, and Polymer-based kits). Optimized transfection protocols provide efficient intracellular delivery of proteins, DNA, and RNA molecules in vitro and in vivo. Read more about transfection technology at Altogen’s Transfection Resource.Altogen Research Services:Altogen Labs provides GLP-compliant contract research studies for pre-clinical research, IND applications, and drug development. Biology CRO services include: Xenograft models (30+), development of stable cell lines, ELISA assay development, cell-based and tissue targeted RNAi studies, safety pharm/tox assays, and other studies (visit AltogenLabs.com). Volume Options:0.5 ml (Catalog #6850)1.5 ml (Catalog #6851)1.5 ml CRISPR (Catalog #2174)8.0 ml (Catalog #7064)

Altogen Biosystems全国代理部分产品列表:

货号

产品

规格

价格(美元)

5030

 

 

 

1703

A204 Transfection Reagent (Rhabdomyosarcoma)

0.5ml

170

1704

A204 Transfection Reagent (Rhabdomyosarcoma)

1.5ml

348

窗体顶端

窗体底端

 

2101

A204 Transfection Reagent (Rhabdomyosarcoma)

1.5ml CRISPR

548

窗体顶端

窗体底端

 

7018

A204 Transfection Reagent (Rhabdomyosarcoma)

8.0ml

1044

窗体顶端

窗体底端

 

1167

A375 Cells Transfection Reagent (CRL-1619)

0.5ml

195

1168

A375 Cells Transfection Reagent (CRL-1620)

1.5ml

427

2102

A375 Cells Transfection Reagent (CRL-1621)

1.5ml CRISPR

627

1169

A375 Cells Transfection Reagent (CRL-1622)

8.0ml

1281

5030

Nanoparticle In Vivo Transfection Reagent

0.5 ml - 10 injections 

445

5010

LIPID In Vivo Transfection Reagent

0.5 ml - 10 injections

405

5040

PEG-Liposome In Vivo Transfection Reagent

0.5 ml - 10 injections

465

5020

POLYMER In Vivo Transfection Reagent

0.5 ml - 10 injections

425

5050

Pancreas In Vivo Transfection Kit

0.5 ml - 10 injections 

495

5060

Liver In Vivo Transfection Kit

0.5 ml - 10 injections 

495

5070

Kidney In Vivo Transfection Kit

0.5 ml - 10 injections 

495

1721

BMS2 Transfection Reagent (Bone Marrow Cells)

0.5 ml 

231

6345

C6 Transfection Reagent (Glioma Cells, CCL-107)

0.5 ml 

199

6803

DLD-1 Transfection Reagent (Colon Cancer, CCL-221)

0.5 ml 

201

1775

HUH-7 Transfection Reagent (Liver Cancer Cells)

0.5 ml 

179

客服在线
service-logo
已有 人查看该问题
tel
全国免费服务热线
4000-520-616
微信公众号
关注我们
手机扫码,关注动态